BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/10/2026 10:11:16 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-01-06 06:26 |
|
Peer-Review Started |
|
2026-01-06 06:26 |
|
First Decision by Editorial Office Director |
|
2026-01-09 09:01 |
|
Return for Revision |
|
2026-01-09 09:01 |
|
Revised |
|
2026-01-17 10:49 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-20 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-20 11:38 |
|
Articles in Press |
|
2026-03-20 11:38 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-17 01:41 |
|
Publish the Manuscript Online |
|
2026-07-10 10:11 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Anti-obesity medications impacting the eye: An emerging concern - a narrative review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Srishti Khullar, Arvind Kumar Morya, Sarita Aggarwal, Arshi Singh, Priya Sisodiya and Rannusha Morya |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arvind Kumar Morya, Additional Professor, Consultant, Principal Investigator, Researcher, Senior Researcher, Department of Ophthalmology, All India Institute of Medical Sciences, Bibi Nagar, Hyderabad 508126, Telangana, India. bulbul.morya@gmail.com |
| Key Words |
Anti-obesity drugs; Ocular side effects; Optic neuropathy; Diabetic retinopathy; Glaucoma |
| Core Tip |
Anti-obesity medicines are being used more than ever, especially glucagon-like peptide-1 receptor agonists and newer incretin-based therapies. Along with clear metabolic benefits, emerging reports suggest potential eye-related complications such as non-arteritic anterior ischemic optic neuropathy, early worsening of diabetic retinopathy, acute angle closure from uveal effusion, and vitamin A-related visual dysfunction. These risks appear biologically plausible through vascular, metabolic, and neuro-ophthalmic pathways, particularly during rapid weight loss or quick glycaemic change. Clinicians should stratify risk, counsel patients on warning symptoms, and ensure timely ophthalmic evaluation. |
| Publish Date |
2026-07-10 10:11 |
| Citation |
Khullar S, Morya AK, Aggarwal S, Singh A, Sisodiya P, Morya R. Anti-obesity medications impacting the eye: An emerging concern - a narrative review. World J Methodol 2026; 16(3): 118520
|
| URL |
https://www.wjgnet.com/2222-0682/full/v16/i3/118520.htm |
| DOI |
https://doi.org/10.5662/wjm.118520 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
